Skip to main content

Table 1 Number of householders declaring adverse effects two weeks and one month after spraying according to the treatment arm

From: Small-scale field testing of alpha-cypermethrin water-dispersible granules in comparison with the recommended wettable powder formulation for indoor residual spraying against malaria vectors in Benin

Time of survey

Treatment

No. of householders surveyed

Number of householders declaring adverse effectsa

Skin itching

Nose running

Sneezing

Eye watering

Headache

Nausea, vomiting, stomach pain

At least one adverse effect

After 2 weeks

WG20

10

1

1

1

1

1

0

2

WG30

10

0

1

2

0

0

0

2

WP20

10

1

1

0

0

0

0

1

WP30

10

0

0

0

0

1

1

1

control

10

0

0

0

0

0

0

0

After 1 month

WG20

10

0

0

0

0

0

0

0

WG30

10

0

1

1

0

1

0

1

WP20

10

0

0

0

0

0

0

0

WP30

10

0

0

1

0

0

0

1

control

10

0

0

0

0

0

0

0

  1. aOnly adverse effects that were declared by at least one householder are listed. Facial burning, eye irritation, excessive sweating, experiencing bad smell after spraying, blurred vision, slurred speech, muscle twitching or other symptoms were not cited by any of the surveyed householders